Great post @Eqz, thank you!
From my reading Zotal have been in the business of med-tech & diagnostics for 30 years in Israel. I think seeing the 6 month time frame for approvals from the Israeli ministry of health & reimbursement arrangements probably turned some off. It was only meant to be 1 month for Italy and I think we are getting close to that now. 1 in 8 adults in Israel have diabetes and an aging population, that’s huge. Israel also keep a register for all patients with ESRD & on dialysis, it’s law & it looks like it’s a serious public health problem in that country:
https://www.health.gov.il/English/Topics/KHealth/diabetes/Pages/default.aspx
The way I see it, 2 distribution deals in a month, where will the next country be?
GLTAH
Ann: Middle East is next market for PromarkerD immunoassay test, page-17
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $60.56M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 38.0¢ | 36.0¢ | $21.95K | 59.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 14937 | 1 |
View Market Depth
| Last trade - 13.43pm 07/08/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |